Home › Funds › Informed Momentum Co LLC › LGND
Informed Momentum Co LLC position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
Informed Momentum Co LLC reported holding 19,711 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$6.2M, representing 0.64% of its reported portfolio and ranking #31 among its reported holdings. Informed Momentum Co LLC has disclosed LGND holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Informed Momentum Co LLC's LGND position evolved
Informed Momentum Co LLC first disclosed a stake in LGND in Q3 2025 at 30,175 shares (US$5.3M). The position peaked in Q2 2026 at 19,498 shares, worth US$6.2M. Across 4 filings, Informed Momentum Co LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 19,711 shares valued at US$6.2M — an increase of 213 shares quarter over quarter.. Notable position changes include a 30% trim in Q4 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 30.18K | $5.26M | New |
| Q4 2025 | 21.09K | $3.99M | Reduce |
| Q2 2026 | 19.50K | $6.16M | New |
| Q3 2026 | 19.71K | $6.16M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 446.14K sh · $139.36M · Q3 2026
- WOLVERINE ASSET MANAGEMENT LLC 50.37M sh · $84.80M · Q3 2026
- GW&K Investment Management, LLC 241.76K sh · $75.52M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 223.91K sh · $69.94M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 192.39K sh · $60.10M · Q3 2026
- Ranger Investment Management, L.P. 185.65K sh · $57.99M · Q3 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 166.34K sh · $51.96M · Q3 2026
- Granahan Investment Management, LLC 154.32K sh · $48.20M · Q3 2026
- SILVERBACK ASSET MANAGEMENT LLC 25.00M sh · $42.00M · Q3 2026
More on Informed Momentum Co LLC
FAQ
How long has Informed Momentum Co LLC held LGND?
Informed Momentum Co LLC has disclosed LGND holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
What is Informed Momentum Co LLC's current position in LGND?
As of Q3 2026, Informed Momentum Co LLC holds 19.71K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $6.16M, representing 0.64% of its reported portfolio and ranking #31.
Has Informed Momentum Co LLC been buying or selling LGND?
In the latest 13F filing (Q3 2026), Informed Momentum Co LLC increased its position in LGND. The position peaked in Q2 2026 at 19.50K shares.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.